TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
TP53 测序和 p53 免疫组化可预测贝伐单抗联合一线化疗治疗子宫内膜癌的疗效:一项 NRG 肿瘤/妇科肿瘤组研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.02506
Thiel, Kristina W; Devor, Eric J; Filiaci, Virginia L; Mutch, David; Moxley, Katherine; Alvarez Secord, Angeles; Tewari, Krishnansu S; McDonald, Megan E; Mathews, Cara; Cosgrove, Casey; Dewdney, Summer; Aghajanian, Carol; Samuelson, Megan I; Lankes, Heather A; Soslow, Robert A; Leslie, Kimberly K